Related Experiment Video
Updated: Jan 7, 2026

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.9K
Brain Atrophy Associated With Risk Variant rs10191329 Extends Beyond Multiple Sclerosis
Cato E A Corsten1, Ana M Marques2, Elisabeth J Vinke3,4
1Department of Neurology, MS Center ErasMS, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Annals of Neurology
|January 5, 2026
Summary
The rs10191329*A genetic variant is linked to earlier brain atrophy in middle-aged adults. This finding suggests broader implications for neurodegeneration beyond multiple sclerosis (MS).
Area of Science:
- Neurogenetics
- Neuroimaging
- Aging
Background:
- The risk allele rs10191329*A is known to correlate with increased disease severity and brain atrophy in multiple sclerosis (MS) patients.
- Understanding the role of genetic factors in age-related brain changes is crucial for public health.
Purpose of the Study:
- To investigate the association between the rs10191329 genetic variant and age-related brain atrophy in a general population.
- To determine if the rs10191329*A allele contributes to brain volume changes in individuals without MS.
Main Methods:
- Utilized a population-based cohort of 4,815 participants aged 45 years and older.
- Analyzed 10,308 magnetic resonance imaging (MRI) scans using cross-sectional and longitudinal approaches.
- Examined the association of the rs10191329*A allele with total brain volume and gray matter volume.
Main Results:
- The rs10191329*A allele was significantly associated with lower total brain volume and gray matter volume in middle-aged participants (under 55 years).
- No significant association was observed between the rs10191329*A allele and brain atrophy in older participants (55 years and older).
Conclusions:
- The rs10191329*A allele may contribute to an earlier onset of brain atrophy in the general population.
- The mechanisms underlying accelerated neurodegeneration influenced by this allele extend beyond the context of multiple sclerosis.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K

